CI-994
-
- Application
- Inhibition (Inh)
- Purpose
- HDAC inhibitor
- Characteristics
- Orally active histone deacetylase (HDAC) inhibitor, IC50 = 0.9, 0.9, 1.2 and >20 μM for HDAC1, HDAC2, HDAC3 and HDAC8 respectively. Mediates G1 cell cycle arrest, inhibits proliferation and induces apoptosis in vitro and in vivo. Increases neuroplasticity during memory extinction. Protects beta cells from cytokine-induced apoptosis.
- Purity
- >98 %
- Chemical Name
- 4-(Acetylamino)-N-(2-aminophenyl)benzamide
- Formula
- C15H15N3O2
- Solubility
- Soluble in DMSO (up to 25 mg/ml)
-
-
- Restrictions
- For Research Use only
-
- Format
- Powder
- Storage
- -20 °C
-
- Background
- PD-123654, N-acetyl-dinaline, GOE-5549,Cytokine,Epigenetics,Apoptosis inducer,Proliferation,Posttranslational modification,Protein deacetylase,Neuroscience,Cell death,Inflammation,Diabetes,Cell cycle,Chromatin
- Molecular Weight
- 269.30
- CAS-No
- 112522-64-2
-